This narrative review explores how specific proteins affect cardiac and brain issues in HIV-infected individuals, indicating potential treatment strategies.
In the context of simian immunodeficiency virus (SIV) infection, this editorial commentary minireview addresses the roles of galectin-3, galectin-9, and interleukin-18 in monocyte activation and turnover. It places particular emphasis on their potential consequences for the emergence of cardiac pathology and encephalitis in human immunodeficiency virus (HIV)-positive individuals. The intricate relationship between these proteins and monocyte activation in HIV/SIV pathogenesis is examined, along with their correlation with neurocognitive impairment and cardiovascular illness. Strategies to prevent or treat these diseases in HIV-positive persons include targeted treatments and personalized medicine approaches that target these biomarkers and pathways.
No takes yet. Share an insight, caveat, or question.
Daungsupawong et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: